Quarterly report pursuant to Section 13 or 15(d)

Debt (Detail Textuals)

v3.20.2
Debt (Detail Textuals) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 05, 2018
Apr. 24, 2020
Nov. 30, 2018
Dec. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Debt Instrument [Line Items]                
Derivative liability       $ 501,400 $ 41,149 $ 14,305,389 $ 501,400 $ 15,958,366
Convertible multi-draw credit agreement issuance costs         $ 63,007      
Unamortized debt discount period         2 years 3 days      
Fair value of derivative liabilities in excess of proceeds           $ 322,644    
Fair value of shares underlying convertible debt         $ 211,523      
Paycheck Protection Program                
Debt Instrument [Line Items]                
Maturity date   Apr. 24, 2022            
Principal amount of promissory Note   $ 116,700            
Interest rate   1.00%            
Excess payroll costs exclude compensation of an individual employee   $ 100,000            
Percentage of forgiveness amount for nonpayroll costs   25.00%            
Amount of salaries   $ 100,000            
Percentage of reduction in annual salary   25.00%            
Multi-Draw Credit Agreement                
Debt Instrument [Line Items]                
Warrant exercise price     $ 0.50     $ 0.50    
Proceeds from related party debt     $ 2,000,000     $ 2,000,000    
Number of warrant issued     2,500,000     5,000,000    
Allocation of debt on the basis of relative fair value     $ 1,684,920     $ 3,283,890    
Allocation of warrant on the basis of relative fair value     315,080     716,110    
Beneficial conversion feature     90,080     1,584,850    
Derivative liability     $ 204,102     516,058    
Proceeds from warrant exercises             3,985,500  
Loss on extinguishment of debt       725,425        
Fair value of derivative liabilities in excess of proceeds           322,644    
Principal amount of promissory Note           4,000,000    
Emerald Financing                
Debt Instrument [Line Items]                
Derivative liability       $ 276,024 41,149 $ 13,356,220 $ 276,024 $ 15,251,413
Emerald Financing | Multi-Draw Credit Agreement                
Debt Instrument [Line Items]                
Maximum amount that can be borrowed over the life of the credit facility $ 20,000,000              
Interest rate percentage 7.00%              
Maturity date Oct. 05, 2022              
Unused portion of the credit facility         13,550,000      
Warrant coverage on the debt facility 50.00%              
Warrant exercise price $ 0.50              
Reduced exercise price of warrant 0.35              
Emerald Health Sciences Inc | Multi-Draw Credit Agreement                
Debt Instrument [Line Items]                
Conversion price $ 0.25              
Amount of capital raise $ 5,000,000              
Emerald Health Sciences Inc | Independent contractor agreement                
Debt Instrument [Line Items]                
Credit facility effected fourth advances         150,000      
Credit facility effected fifth advances         $ 300,000